BELRAPZO 100 mg/4mL
bendamustine hydrochloride · INJECTION · Eagle Pharmaceuticals, Inc
BELRAPZO is a injection containing bendamustine hydrochloride at 100 mg/4mL, taken intravenous. Manufactured by Eagle Pharmaceuticals, Inc.
Key Facts
- Brand Name
- BELRAPZO
- Generic Name
- bendamustine hydrochloride
- NDC Code (Product)
42367-521- Manufacturer
- Eagle Pharmaceuticals, Inc
- Strength
- 100 mg/4mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA205580
- Marketing Start
- 06/03/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is BELRAPZO used for?
BELRAPZO contains bendamustine hydrochloride. It is a injection taken intravenous. Consult your doctor for specific uses.
Is BELRAPZO a controlled substance?
BELRAPZO is not classified as a controlled substance by the DEA.
What is the generic name for BELRAPZO?
The generic name for BELRAPZO is bendamustine hydrochloride. There are 11 other brand versions of bendamustine hydrochloride.
What is the NDC code for BELRAPZO 100 mg/4mL?
The NDC (National Drug Code) for BELRAPZO 100 mg/4mL is 42367-521, listed by Eagle Pharmaceuticals, Inc.
Other Bendamustine Brands
See all →- bendamustine hydrochloride100 mg/20mL68001-572
- VIVIMUSTA25 mg/mL24338-270
- BENDAMUSTINE HYDROCHLORIDE25 mg/5mL55150-391
- BENDAMUSTINE HYDROCHLORIDE100 mg/20mL55150-392
- Bendeka25 mg/mL63459-348
- BENDAMUSTINE HYDROCHLORIDE100 mg/4mL83831-183
- TREANDA25 mg/5mL63459-390
- bendamustine hydrochloride100 mg/20mL16729-251
- VIVIMUSTA25 mg/mL71225-120
- BENDAMUSTINE HYDROCHLORIDE100 mg/110019-079
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)